In conclusion, our results, demonstrated for the first time that TRIM29 is overexpressed in cervical cancer and is a potential prognostic biomarker of cervical cancer, which provides additional information for guiding therapeutic strategy. Here, TRIM29 is linked to cervical carcinoma.